Pacira Pharmaceuticals reported $225.79M in Current Liabilities for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Acelrx Pharmaceuticals ACRX:US $ 17.07M 1.88M
Adamas Pharmaceuticals ADMS:US 23.84M 2.02M
Aerie Pharmaceuticals AERI:US $ 118.13M 10.04M
Amerisourcebergen ABC:US $ 41358.64M 1768.8M
Astellas Pharma 4503:JP Y 554768M 26812M
Biodelivery Sciences International BDSI:US $ 77.66M 13.75M
Bristol Myers Squibb BMY:US $ 21460M 2469M
Cara Therapeutics CARA:US $ 15.53M 358K
Coherus Biosciences CHRS:US $ 320.35M 33.3M
Depomed DEPO:US $ 100.48M 16.43M
Endo International Ordinary Shares ENDP:US $ 1554.27M 145.06M
Flexion Therapeutics FLXN:US $ 43.99M 4.06M
Heron Therapeutics HRTX:US $ 72.3M 9.85M
Horizon Pharma HZNP:US $ 854.04M 1.23M
Ironwood Pharmaceuticals IRWD:US $ 145.69M 11.32M
JAZZ PHA JAZZ:US $ 735.05M 145.54M
Lannett LCI:US $ 112.28M 21.81M
Ligand Pharmaceuticals LGND:US $ 36.3M 16.2M
Nektar Therapeutics NKTR:US $ 139.97M 8.95M
Omeros OMER:US $ 42.82M 4.88M
Pacira Pharmaceuticals PCRX:US $ 225.79M 2.9M
Perrigo Ordinary Shares PRGO:US $ 2003.8M 19.3M
Revance Therapeutics RVNC:US $ 65.87M 7.63M
Supernus Pharmaceuticals SUPN:US $ 234.71M 48.74M
Teva Pharmaceutical TEVA:IT 11.82B 866M
Xeris Pharmaceuticals Inc XERS:US $ 37.28M 1.82M
Xoma XOMA:US $ 6.51M 221K
Zoetis ZTS:US $ 1471M 620M